Skip to content
‹ Back to IndustriesSciences

Trends in Pet and Animal Wellbeing

The article discusses the integration of nutrition, supplements, and wellness trends from human health into pet and animal health. It highlights the importance of maintaining pets' health through a combination of a high-quality diet, regular exercise, and veterinary care. Experts from ADM Nutrition emphasize the growing role of supplements in supporting pet microbiome and overall well-being.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Michelle Dawn Mooney · · Animal SupplementsAnimal WellbeingMicrobiomePet Health
Share
Trends in Pet and Animal Wellbeing

Key takeaways

01

A pet's health and wellness depend on a quality diet, regular exercise, routine veterinary care, and appropriate supplements.

02

Supplements such as prebiotics, probiotics, and postbiotics support a healthy microbiome in pets, which is crucial for their overall health.

03

Consumers should research pet supplements to ensure they are beneficial and effective.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Nutrition, supplements, and wellness are the foundation for a healthy human life. And that trend is now leaking into our pets and animal health. According to a recent Pet Age report, “a pet’s health and wellness is a three-dimensional sphere that includes several interdependent parts including a high-quality diet, regular exercise, routine veterinary care, a loving home, and supplements to support health.”

Caitlin Donohue, Director of Business Development Microbiome Solutions, Pet & Animal Wellbeing, ADM Nutrition, pointed out, “it’s a lot cheaper to prevent problems than to treat them.” She and her colleague, Bill Bae, Business Development Director, Market Ready Solutions – NA&LATAM, Pet and Animal Wellbeing, ADM Nutrition, sat down with host Michelle Dawn Mooney to discuss supplement care for pets. Bae continued, “having those supplements… is really beneficial for your pets in general.”

Consumers should expect to see more supplements for their pets’ microbiome. The term microbiome describes a community of different organisms. The gut microbiome and oral microbiome are the most studied. Each community is a competition between desirable bacteria and undesirable bacteria. A healthy microbiome is usually reflective of overall good health.

Supporting supplemental ingredients include pre-, pro-, and post-biotics. “The prebiotic is the food that the probiotics need,” explained Bae. A newer term, postbioitics, are organisms that are no longer living. “Each provides a health benefit. Post is derived from the probiotic, and ultimately promoting a more diverse, beneficial microbiome for the host, be it a dog, cat, or human,” explained Donohue.

Enzyme-focused supplements help facilitate proper digestion. “Enzymes are another way to support a breakdown of other various diets for cats and dogs,” said Donohue. These can help balance pet diets and support overall well-being. “Systemic enzymes support bodily functions within the tissues, organs, blood flow, things like that,” said Donohue.

Bae warns that consumers should do their research when buying pet supplements. Carefully look at what is going into your pet’s gut flora. Bae says there are “macro terms that cover a lot of things.” Delivering supplements is possible in various forms, from single-serve packs, chews, broths, pastes, or gels.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

MD

Michelle Dawn Mooney is a media professional and host known for her work in broadcast journalism and B2B content.

B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Celliaz is betting on one AAV2 vector for an eye disease with 90-plus gene causes

Celliaz is betting on one AAV2 vector for an eye disease with 90-plus gene causes

Andelyn Biosciences will develop and manufacture CLZ002, Celliaz's AAV2 gene therapy for retinitis pigmentosa, through IND-enabling work and a planned Phase 1/2 trial. CLZ002 targets retinal repair, not mutations. Because the disease is linked to more than 90 genes, one manufacturing process could end up serving a broad patient group.

  • 01Retinitis pigmentosa has more than 90 causal genes; CLZ002 aims at a shared retinal repair pathway, so a single AAV2 manufacturing process would serve patients that gene-specific programs would split into many products.
  • 02For a pre-IND sponsor, putting plasmid and viral vector production with one CDMO can mean fewer handoffs, and the questions worth settling early are who owns the process built on a proprietary platform and how it would move if needed.

Nov 14, 2026

Lab Manager survey finds 2027 lab hiring budgets nearly flat while supply budgets grow

Lab Manager survey finds 2027 lab hiring budgets nearly flat while supply budgets grow

Lab hiring budgets for 2027 carry a net outlook of just +2, down from +10, while consumables sit at +30 and raw materials at +31. Labs are paying for supplies and planning capital purchases further ahead. New positions face the toughest scrutiny.

  • 01Labs heading into 2027 expect their reagent budgets to grow and their headcount budgets to stall: consumables carry a net outlook of +30, hiring just +2.
  • 02Lab Manager’s read: if consumables spending stays flat, the lab is probably buying less—because respondents reported rising costs across many supply items, from reagents to shipping.
  • 03Hiring gets treated as a recurring cost, not a one-time purchase; one published example estimates ~$46,000/year for a graduate student and $80,000–$100,000 for a postdoc (with fringe) at one institution. Lab Manager recommends justifying new roles with throughput, turnaround and risk—while separating price from volume in supply-line requests.

Nov 13, 2026

Simtra opens $250 million-plus Bloomington building with three sterile filling lines

Simtra opens $250 million-plus Bloomington building with three sterile filling lines

Simtra BioPharma Solutions opened Building H, a $250 million-plus addition to its Bloomington, Indiana campus, featuring two syringe lines and a vial line with lyophilizers. The CDMO plans to expand from 11 to 18 filling lines by 2027. Extra sites reduce supply risk only when products are qualified at both locations.

  • 01Simtra's network is set to grow from 11 to 18 filling lines across Indiana and Germany by 2027, a published capacity timeline sponsors can plan tech transfers against.
  • 02A second fill site cuts supply risk only after a product has been validated there; for biologics that means process validation, comparability work and regulatory filings first.
  • 03Programs whose real exposure sits in concentrated starting-material supply gain little from added fill-finish redundancy, however well the new lines are built.

Nov 13, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Experts

Michelle Dawn Mooney is a media professional and host known for her work in broadcast journalism and B2B content.

CD
Caitlin Donohue

Director of Business Development Microbiome Solutions, Pet & Animal Wellbeing

ADM Nutrition

Caitlin Donohue focuses on microbiome solutions and animal well-being in her role at ADM Nutrition.

BB
Bill Bae

Business Development Director, Market Ready Solutions – NA&LATAM, Pet and Animal Wellbeing

ADM Nutrition

Bill Bae specializes in market solutions for pet and animal well-being at ADM Nutrition.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512